Long‐term survival and conditional survival of cancer patients in Japan using population‐based cancer registry data

Author:

Ito Yuri1,Miyashiro Isao1,Ito Hidemi2,Hosono Satoyo2,Chihara Dai2,Nakata‐Yamada Kayo1,Nakayama Masashi3,Matsuzaka Masashi4,Hattori Masakazu5,Sugiyama Hiromi6,Oze Isao2,Tanaka Rina4,Nomura Etsuko1,Nishino Yoshikazu7,Matsuda Tomohiro8,Ioka Akiko1,Tsukuma Hideaki1,Nakayama Tomio1,

Affiliation:

1. Center for Cancer Control and Statistics Osaka Medical Center for Cancer and Cardiovascular Diseases OsakaJapan

2. Division of Epidemiology and Prevention Aichi Cancer Research Institute NagoyaJapan

3. Department of Urology Osaka Medical Center for Cancer and Cardiovascular Diseases OsakaJapan

4. Department of Cancer Epidemiology and Community Health Hirosaki University Graduate School of Medicine HirosakiJapan

5. Department of Cancer Therapy Center Fukui Prefectural Hospital FukuiJapan

6. Department of Epidemiology Radiation Effects Research Foundation HiroshimaJapan

7. Division of Epidemiology Miyagi Cancer Center Research Institute NatoriJapan

8. Surveillance Division Center for Cancer Control and Information Services National Cancer Center Tokyo Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3